People with diabetes have a higher risk of developing Alzheimer's disease (AD) raising a possible link between the cells that ...

Compounding Pharmacy Service Market. The Compounding Pharmacy Service market is set to exhibit significant growth, driven by the rising prevalence of chron ...

The global cannabis and hemp market is experiencing dynamic changes driven by several factors. Growing consumer awareness about the therapeutic benefits ...

Quibim says its longer-term plan is to create digital twins of the entire human body, serving “dynamic models” that help the ...

The implications of Trump's broad pause on federal grants and loans weren't immediately clear, but could be sweeping.

Ciena (NYSE:CIEN) was upgraded to Overweight from Neutral by J.P. Morgan following a 21% plunge on Monday related to DeepSeek ...

Vaccine policy looms over upcoming HHS confirmation hearings. We analyzed RFK Jr.’s views on liability protection, adverse ...

Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.

Nanoarchitected materials represent a transformative leap in material science, combining strength, lightweight properties, ...

Naporafenib is Erasca’s main candidate, and it has Fast Track status for NRASm melanoma. See why I rate ERAS stock as a buy.

Cancer is a leading cause of death worldwide but several ASX biotechs are focused on early detection and treatment to improve ...

Fresh off of his unexpected departure from President Donald Trump's Department of Government Efficiency, Vivek Ramaswamy has ...